In addition, studies of IL-1β, IL-11, IL-17, IL-18, and TNF also indicate that proinflammatory cytokines are key regulators for TME in inhibiting tumor cell proliferation, reducing inflammation, and preventing tumor metastasis [29, 30]. Here, IL1B is linked to neoplasm.